Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

ETR/AMG stock hub

ETR/AMG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/AMGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

152.1B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/AMG

In the news

Latest news · ETR/AMG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 12.3P50 15.7P75 20.2

Trailing P/E22.5

P25 16.4P50 20.9P75 30.4

ROE101.3

P25 -6.7P50 8.5P75 17.2

ROIC19.1

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/AMG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	31,500
Employees Change	3,500%
Employees Change Percent	12.5
Enterprise value	EUR 190.6B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US0311621009
Last refreshed	2026-05-10
Market cap	EUR 152.1B
Price	EUR 280
Price currency	EUR
Rev Per Employee	1,024,790.67x
Sector	Healthcare
Sic	2836
Symbol	etr/AMG
Website	https://www.amgen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.45%
EV Earnings	28.17x
EV/EBIT	18.47x
EV/EBITDA	13.06x
EV/FCF	25.56x
EV/Sales	6.03x
FCF yield	4.9%
Forward P/E	14.61x
P/B ratio	19.08x
P/E ratio	22.48x
P/S ratio	4.71x
PE Ratio10 Y	25.07x
PE Ratio3 Y	28.82x
PE Ratio5 Y	25.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.63%
EBITDA Margin	45.45%
FCF margin	23.1%
Gross margin	71.44%
Gross Profit	EUR 23.1B
Gross Profit Growth	12.82%
Gross Profit Growth Q	10.41%
Gross Profit Growth3 Y	10.66%
Gross Profit Growth5 Y	6.92%
Net Income	EUR 6.8B
Net Income Growth	31.47%
Net Income Growth Q	5.15%
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Net Income Growth3 Y	-0.5%
Net Income Growth5 Y	1.94%
Pretax Margin	24.41%
Profit Margin	20.96%
Profit Per Employee	EUR 214,760
Profitable Years	23
ROA	8.35
Roa5y	8.22
ROCE	17.98
ROE	101.3
Roe5y	101.8
ROIC	19.05
Roic5y	20.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.98%
Cagr15y	16.96%
Cagr1y	19.94%
Cagr3y	13.02%
Cagr5y	9.45%
Div CAGR10	10.65%
Div CAGR3	3.13%
Div CAGR5	8.2%
EPS Growth	31.3
EPS Growth Q	4.38
EPS Growth Quarters	5
EPS Growth Years	1
EPS Growth3 Y	-0.8
EPS Growth5 Y	3.54
FCF Growth	-21.24%
FCF Growth Q	50.71%
FCF Growth3 Y	4.51%
FCF Growth5 Y	-2.65%
OCF Growth	-11.78%
OCF Growth Q	57.37%
OCF Growth10 Y	0.57%
OCF Growth3 Y	7.65%
OCF Growth5 Y	0.55%
Revenue Growth	9.07x
Revenue Growth Q	5.76x
Revenue Growth Quarters	12x
Revenue Growth Years	6x
Revenue Growth3 Y	12.43x
Revenue Growth5 Y	8.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.41
Assets	EUR 80.2B
Cash	EUR 10.4B
Current Assets	EUR 26.7B
Current Liabilities	EUR 21.2B
Debt	EUR 49.7B
Debt EBITDA	EUR 3.34
Debt Equity	EUR 6.24
Debt FCF	EUR 6.67
Equity	EUR 8B
Interest Coverage	3.92
Liabilities	EUR 72.3B
Long Term Assets	EUR 53.5B
Long Term Liabilities	EUR 51.1B
Net Cash	EUR -39.3B
Net Cash By Market Cap	EUR -25.82
Net Debt EBITDA	EUR 2.68
Net Debt Equity	EUR 4.93
Net Debt FCF	EUR 5.27
Tangible Book Value	EUR -26.8B
Tangible Book Value Per Share	EUR -49.6
WACC	6.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.26
Inventory Turnover	1.65
Net Working Capital	EUR -70.3M
Quick ratio	0.85
Working Capital	EUR 5.7B
Working Capital Turnover	EUR 6.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.09%
Dividend Growth	-1.96%
Dividend Growth Years	15%
Dividend per share	EUR 8.36
Dividend Years	16
Dividend Yield	2.99%
Ex Div Date	2026-02-13
Last Dividend	EUR 2.12
Payout Frequency	Quarterly
Payout Ratio	67.11%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	183.37%
1Y total return	19.93%
200-day SMA	278.7
3Y total return	44.36%
50-day SMA	303.9
50-day SMA vs 200-day SMA	50over200
5Y total return	57.04%
All Time High	333
All Time High Change	-16.02%
All Time High Date	2026-03-02
All Time Low	25.82
All Time Low Change	983.08%
All Time Low Date	2008-04-04
ATR	6.16
Beta	0.44
Ch YTD	-0.23
High	282.9
High52	333
High52 Date	2026-03-02
High52ch	-16.02%
Low	279.7
Low52	230
Low52 Date	2025-09-17
Low52ch	21.59%
Ma50ch	-7.99%
Price vs 200-day SMA	0.36%
RSI	37.39
RSI Monthly	51.38
RSI Weekly	44.86
Sharpe ratio	0.68x
Sortino ratio	1.32
Total Return	2.9%
Tr YTD	0.46
Tr15y	949.13%
Tr1m	-4.25%
Tr1w	0.81%
Tr3m	-11.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 10.5B
Operating Income Growth	18.32
Operating Income Growth Q	24.43
Operating Income Growth3 Y	8.22
Operating Income Growth5 Y	5.8
Operating margin	32.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	538,255,159%
Net Borrowing	13,567,392
Shares Insiders	0.17%
Shares Institutions	82.91%
Shares Qo Q	0.18%
Shares Yo Y	0.09%
Short Ratio	4.77

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 7B
Average Volume	328.4x
Bv Per Share	14.77
CAPEX	EUR -1.9B
Ch10y	110.5
Ch15y	613.4
Ch1m	-4.25
Ch1w	0.81
Ch1y	16.28
Ch3m	-12.2
Ch3y	31.41
Ch5y	34.25
Ch6m	0.83
Change	0.36%
Change From Open	-1.15
Close	278.7
Days Gap	1.53
Depreciation Amortization	4,046,474,664
Dollar Volume	12,304.6
Earnings Date	2026-04-30
EBIT	EUR 10.5B
EBITDA	EUR 14.7B
EPS	EUR 12.46
F Score	8
FCF	EUR 7.5B
FCF EV Yield	3.91x
Financing CF	-4,610,566,800
Fiscal Year End	December
Founded	1,980
Goodwill	15,834,842,388
Graham Number	64.04149
Graham Upside	-77.1
Income Tax	EUR 1.1B
Investing CF	-1,918,467,600
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	1999-11-22
Last Split Type	Forward
Lynch Fair Value	EUR 62.19
Lynch Upside	-77.76
Ma150	289.4
Ma150ch	-3.36%
Ma20	291.2
Ma20ch	-3.98%
Net CF	2,799,644,400
Next Earnings Date	2026-08-04
Open	282.9
P FCF Ratio	20.4
P OCF Ratio	16.3
Payment Date	2026-03-06
Position In Range	0
Ppne	6,966,855,792
Price Date	2026-05-08
Price EBITDA	EUR 10.37
Relative Volume	0.13x
Revenue	32,280,906,000x
SBC By Revenue	1.3x
Share Based Comp	419,773,200
Tax By Revenue	3.46x
Tax Rate	14.16%
Tr6m	2.25%
Volume	44
Z Score	1.75

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/AMG dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.0%

$8.36 annual per share

Payout ratio

+67.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+8.2%

15 consecutive years of growth

Total shareholder yield

+2.9%

Next ex-dividend date: 2026-02-13

Performance

ETR/AMG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/AMG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+82.9%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/AMG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.4

Neutral momentum band

Price vs 200-day MA

+0.4%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/AMG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/AMG stock rating?

etr/AMG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/AMG analysis?

The full report lives at /stocks/etr/AMG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/AMG?

The latest report frames etr/AMG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/AMG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.